Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other Accumulated Expenses (2022 - 2024)

Historic Other Accumulated Expenses for Immuneering (IMRX) over the last 3 years, with Q3 2024 value amounting to $59657.0.

  • Immuneering's Other Accumulated Expenses fell 2588.92% to $59657.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $59657.0, marking a year-over-year decrease of 2588.92%. This contributed to the annual value of $259770.0 for FY2023, which is 121223.48% up from last year.
  • Per Immuneering's latest filing, its Other Accumulated Expenses stood at $59657.0 for Q3 2024, which was down 2588.92% from $90242.0 recorded in Q2 2024.
  • Immuneering's 5-year Other Accumulated Expenses high stood at $259770.0 for Q4 2023, and its period low was $19796.0 during Q4 2022.
  • Moreover, its 3-year median value for Other Accumulated Expenses was $47213.0 (2022), whereas its average is $65931.8.
  • Within the past 5 years, the most significant YoY rise in Immuneering's Other Accumulated Expenses was 121223.48% (2023), while the steepest drop was 4422.51% (2023).
  • Quarter analysis of 3 years shows Immuneering's Other Accumulated Expenses stood at $19796.0 in 2022, then soared by 1212.23% to $259770.0 in 2023, then crashed by 77.03% to $59657.0 in 2024.
  • Its Other Accumulated Expenses was $59657.0 in Q3 2024, compared to $90242.0 in Q2 2024 and $23634.0 in Q1 2024.